Sunday, March 30, 2008

Pharma CEO Money

The Wall Street Journal has the numbers.

Pfizer: John LaMattina [Research Chief] left the company last year after the failure of their cholesteral drug torcetrapib. "His exit package was worth:

$22.6 Million."

Pfizer: David Shedlarz [former CEO] "His exit package was worth:

$34.2 Million."

Merck: Dick Clark [CEO] whose compensation package for 2007 was:

$19.9 Million

Wyeth: Robert Essner [CEO] grabbed $32.9 Million in 2006 and in 2007:

$24.1 Million

Abbot: Miles White [CEO] in 2007 grabbed himself a package worth:

$33.4 Million

Bristol Myers Squibb: James Cornelius [CEO] grabbed himself:

$11.3 Million

Johnson & Johnson: William Weldon [CEO] as reported already, grabbed:

$31.9 Million


Pfizer: Geodon
Bristol Myers Squibb: Abilify
Wyeth: Effexor
Johnson & Johnson: Risperdal

Geodon, Abilify and Risperdal are atypical antipsychotics.
Effexor is advertised for the Treatment of 'Social Anxiety Disorder'.

Andrea Yates was 'Treated' with Effexor and Risperdal.

No comments:

Post a Comment

All standard cautions apply. Your milage may vary.

So Try to be an Adult, [no carpet F bombings, Pron, open threats, etc.] and not a Psychiatrist, about it. Google account, for now, is no longer required to comment, but moderation is in effect.